skip to Main Content


Celebrating 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."


Medicare 2022 Conversion Factor Update

Thanks to lobbying efforts from the House of Medicine, Congress took action this month. The…

Read more

CY 2022 Physician Fee Schedule Proposed Rule Summary

On July 13, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…

Read more

Congress Considers Extension of Telehealth Flexibilities Post-Pandemic

The COVID-19 pandemic forced Congress and the Centers for Medicare & Medicaid Services (CMS) to…

Read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

12/01/22: Research Grant Cycle
Learn more

04/01/23: Fellow Exam Application Deadline
Learn more

06/01/23: Research Grant Cycle
Learn more

06/26/23: Membership Application Deadline to be eligible for AAOA Member rate for the 2023 Basic Course

07/01/23: Scientific Abstract Submission Deadline
Learn more


The hybrid 2023 AAOA Advanced Course in Allergy & Immunology will take place from Thursday, March 30 - Saturday, April 1, 2023 at the Hythe, Vail, CO (formerly known as the Vail Marriott Mountain Resort). The live–stream content and pre-work will be made available to virtual attendees and live attendees via the Whova app with the pre-work content releasing on March 1, 2023. Learn More and Register Now


For information about Resident opportunities, DosedDaily, research grants, and other resources. Learn More


Available Now


IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

AAOA Educational Stacks
October 15-December 31, 2022

2023 AAOA Advanced Course in Allergy & Immunology
March 30 - April 1, 2023
The Hythe Vail
Formerly the Vail Marriott Mountain Resort
Learn More and Register

2023 AAOA Basic Course in Allergy & Immunology
June 29 – July 1, 2023
Hyatt Regency Seattle
Learn More and Register

2023 AAOA Annual Meeting
September 28 – September 30, 2023
Embassy Suites by Hilton Nashville Downton

USP 797 Online Module
Learn More and Register

News and Updates

USP General Chapter Released

After a multi-year effort, the long-awaited revision of Chapter 797 Standards for Sterile Compounding (797) of…

Read more

Sore Throat Becoming Dominant COVID Symptom

You are encouraged to remain vigilant when any symptoms of URI emerge, especially as COVID…

Read more
College Allergy Symptoms Treatment Back to Shcool


AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More


AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>


COVID-19 Vaccines – AAOA Zoomcast

A brief summary of the COVID-19 Vaccines – AAOA Zoomcast Series: Just In Time Content for AAOA Members, Part II. Written by Haidy Marzouk, MD, FAAOA.

*Information related to COVID 19 is rapidly evolving

Panelists: Michelle Liu, MD; Nalin Patel, MD; Robert Stachler, MD.

Moderator: Jennifer Villwock, MD.

Discussion Questions:

  1. What is your most effective way to describe to others how the COVID19 vaccine works?
    1. The vaccine will teach the immune system to recognize the virus and neutralize it.
    1. It is not a live vaccine.
    1. We should all try to get vaccinated ASAP in an effort to develop herd immunity
    1. There are some side effects related to inflammatory response that people will get that are not severe.  These are worth it to protect ourselves and those around us.
  2. What concerns have people brought up to you regarding the vaccine?
    1. Severe allergic reaction – the current literature quotes the rate of severe reaction as 1.3/1Million
    1. Concerns regarding infertility from the vaccine – there is no literature to support this
      1. We have to counsel our patients to be cautious regarding a lot of misinformation circulating
    1. Safety – The vaccine is very safe.  There is an inflammatory response that occurs with the vaccine that is expected such as fever, fatigue, arm soreness, and body ache.  This is temporary and not dangerous
  3. How to approach hesitancy toward the vaccine?
    1. This is not related to level of education
    1. Early research shows that 14% of African Americans trust that it is safe and 34% of Latinos
      1. There are historical reasons for this
    1. Reassure people that this is NOT a live vaccine
    1. Be transparent that we looked into our own personal concerns and are willing to be vaccinated
  4. How to approach concerns regarding vaccine safety?
    1. There has been some sensationalization regarding the rate of severe allergic reactions from the vaccine.
    1. CDC reported a rate of 1.3/million doses
      1. Many related to ingredient polyethylene glycol, which is in many household products
      1. This is not a reason to not receive the vaccine
  5. What about the incidence of large local reactions that are delayed?
    1. Most of the reactions occur within 15 minutes
      1. Observation period can be considered for many
    1. Most have soreness at the site and muscle pain
    1. Few reports of nausea and lightheadedness, mild
    1. Fever/body aches for up to 3 days – more common after the second dose
    1. 0.2% rate of delayed large local reaction – not dangerous and often helped with antihistamines
  6. What about those receiving immunomodulators/immunotherapy?
    1. SCIT – can consider spacing out vaccine and allergy shot 3-5 days apart
    1. SLIT – can consider holding SLIT for that week
  7. What about patients receiving biologics?
    1. No issues or need to change biologic therapy around the time of the vaccine
    1. Those who are immune compromised are strongly recommended to receive the vaccine given it is not live and can be protective.
  8. Where to refer patients to for more information?
    1. AAOA website – patient information section for vaccine FAQs
    1. Hopkins website
    1. CDC website
    1. Be cautious regarding the source of information provided
    1. Encourage others to understand the history of distrust among certain populations (Syphilis experiments etc.)
  9. Do you intend to change PPE practices in the office once you and our staff are vaccinated?
    1. Vaccine effectiveness studies were in the context of social distancing.  We don’t know how much it will change without distancing.
    1. We know about effectiveness but not transmission yet.
    1. No panelist intends to change PPE protocol for now.
  10. Closing thoughts
    1. Continue to be vigilant no matter what part of the country you practice in and what the current rates are.  This is true both inside and outside of work.
    1. Be sensitive and supportive when people are hesitant.

VIew the COVID-19 Vaccines Zoomcast.

Back To Top